Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cope

Showing results (161-170 of 187) with videos related to

Pageof 19
Sort By:
Science Signaling|October 6, 2016
Superresolution imaging of the cytoplasmic phosphatase PTPN22 links integrin-mediated T cell adhesion with autoimmunityGarth L Burn, Georgina H Cornish, Katarzyna Potrzebowska, et al.
The Lancet. Rheumatology|January 22, 2024
Gout incidence and management during the COVID-19 pandemic in England, UK: a nationwide observational study using OpenSAFELYMark D Russell, Jon Massey, Edward Roddy, et al.
Rheumatology (Oxford, England)|June 5, 2025
Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort studyMaryam A Adas, Katie Bechman, Mark D Russell, et al.
Nature Communications|February 1, 2019
The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cellsEsperanza Perucha, Rossella Melchiotti, Jack A Bibby, et al.
BMJ Open|March 3, 2026
Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocolBenjamin A Fisher, Anna Rowe, Chris Hodson, et al.
The Lancet. Rheumatology|November 15, 2021
Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort studySatveer K Mahil, Katie Bechman, Antony Raharja, et al.
Plos One|October 10, 2019
Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 casesMatthew Traylor, Rachel Knevel, Jing Cui, et al.
The Lancet. Rheumatology|June 30, 2026
Trends in autoimmune rheumatic disease diagnoses before and after the COVID-19 pandemic in England: a population-based cohort study using OpenSAFELYMark D Russell, Andrea Schaffer, Zijing Yang, et al.
The Lancet. Rheumatology|July 14, 2021
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort studySatveer K Mahil, Katie Bechman, Antony Raharja, et al.
BMJ (Clinical Research Ed.)|January 21, 2026
Time trends in newly recorded diagnoses of 19 long term conditions before, during, and after the covid-19 pandemic: population based cohort study in England using OpenSAFELYMark D Russell, Andrea Schaffer, Katie Bechman, et al.
Pageof 19

Showing results (161-170 of 187) with videos related to

Sort By:
Pageof 19
Science Signaling|October 6, 2016
Superresolution imaging of the cytoplasmic phosphatase PTPN22 links integrin-mediated T cell adhesion with autoimmunityGarth L Burn, Georgina H Cornish, Katarzyna Potrzebowska, et al.
The Lancet. Rheumatology|January 22, 2024
Gout incidence and management during the COVID-19 pandemic in England, UK: a nationwide observational study using OpenSAFELYMark D Russell, Jon Massey, Edward Roddy, et al.
Rheumatology (Oxford, England)|June 5, 2025
Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort studyMaryam A Adas, Katie Bechman, Mark D Russell, et al.
Nature Communications|February 1, 2019
The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cellsEsperanza Perucha, Rossella Melchiotti, Jack A Bibby, et al.
BMJ Open|March 3, 2026
Pragmatic, open-label, multicentre, randomised controlled trial to guide initial therapy for immune checkpoint inhibitor-induced inflammatory arthritis comparing standard of care (prednisolone) to adalimumab without glucocorticoids: REACT trial protocolBenjamin A Fisher, Anna Rowe, Chris Hodson, et al.
The Lancet. Rheumatology|November 15, 2021
Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort studySatveer K Mahil, Katie Bechman, Antony Raharja, et al.
Plos One|October 10, 2019
Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 casesMatthew Traylor, Rachel Knevel, Jing Cui, et al.
The Lancet. Rheumatology|June 30, 2026
Trends in autoimmune rheumatic disease diagnoses before and after the COVID-19 pandemic in England: a population-based cohort study using OpenSAFELYMark D Russell, Andrea Schaffer, Zijing Yang, et al.
The Lancet. Rheumatology|July 14, 2021
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort studySatveer K Mahil, Katie Bechman, Antony Raharja, et al.
BMJ (Clinical Research Ed.)|January 21, 2026
Time trends in newly recorded diagnoses of 19 long term conditions before, during, and after the covid-19 pandemic: population based cohort study in England using OpenSAFELYMark D Russell, Andrea Schaffer, Katie Bechman, et al.
Pageof 19